Companies Cryptocurrencies
AnPac Bio-Medical Science Co Ltd
AnPac Bio-Medical Science Co Ltd
Exchange: NasdaqGM
IPO Date: 30/01/2020
CEO: Dr. Chris Chang Yu
Biotechnology Healthcare 🔗
  • ANPC
  • 0.2422
  • 9508845
    market cap
  • 0.0052
If you bought

shares of AnPac Bio-Medical Science Co Ltd (ANPC) on
You would have made
Old Price $12 Current Price $12

AnPac Bio-Medical Science Co., Ltd. is a China-based biotechnology company focused on early cancer screening and detection. The Company markets and sells multi-cancer screening and detection test that uses cancer differentiation analysis (CDA), technology and its cancer-detection device or CDA device. In addition to early cancer screening and detection, its CDA technology assists physicians in cancer diagnosis, prognosis and recurrence. Its CDA technology provides a platform on which it has developed cancer screening and detection test using its CDA technology, or CDA test, and its CDA device. Its CDA technology focuses on biophysical properties in human blood. The Company have established two clinical laboratories in China and one clinical laboratory in the United States.

Address: Lishui ZHEJIANG 323006

Stay updated.